Mark Alexander Schobel Net Worth & Insider Trades
Mark Alexander Schobel - Chief Innovation/Tech Officer, Aquestive Therapeutics, Inc
What is Mark Alexander Schobel's Net Worth?
The current estimated net worth of Aquestive Therapeutics, Inc's Chief Innovation/Tech Officer, Mark Alexander Schobel, is estimated to be about $2.6M . Mark Alexander Schobel owns about 882,871 units of Aquestive Therapeutics, Inc common stock. In the last 5 years at Aquestive Therapeutics, Inc, Mark Alexander Schobel has sold an estimated value of $1.63M worth.
What is Mark Alexander Schobel's Past Insider Trading?
Mark Alexander Schobel's largest purchase order was 45,871 units , worth over $44.04K on June 10, 2022. Mark Alexander Schobel's largest sale order was 80,000 units , worth over $308K on May 4, 2020. In total, Mark Alexander Schobel has made about 35 transactions over 5 years of their time at Aquestive Therapeutics, Inc. Mark Alexander Schobel usually trades in March, with the busiest year in 2020 and 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mark Alexander Schobel
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Mark Alexander Schobel's' Mailing Address?
- Mailing address is 30 Technology Drive Warren NJ 07059 NJ
What are Aquestive Therapeutics, Inc's Past Insider Trades?
Aquestive Therapeutics, Inc's most recent insider trade came on June 15, 2022 by Peter Boyd who bought 5,000 units worth $4.05K . In the last 4 years, insiders at Aquestive Therapeutics, Inc have sold an estimated value of $2.35M and bought an estimated value of $3.13M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Mark Alexander Schobel, Chief Innovation/Tech Officer, Keith Kendall, CEO and President, and Daniel Barber, President and CEO .
Aquestive Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |